XORTX Therapeutics Inc.
XRTX.V
TSX
Weiss Ratings | XRTX.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D- | |||
Reward Grade | E | |||
Rating Factors | XRTX.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Excellent | |||
Total Return Index | Very Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | XRTX.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Beta | -0.31 | |||
Price History | XRTX.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 2.90% | |||
30-Day Total Return | 5.97% | |||
60-Day Total Return | -16.47% | |||
90-Day Total Return | -17.92% | |||
Year to Date Total Return | -14.46% | |||
1-Year Total Return | -68.23% | |||
2-Year Total Return | -73.70% | |||
3-Year Total Return | -93.40% | |||
5-Year Total Return | -91.60% | |||
52-Week High % Change | -74.25% | |||
52-Week Low % Change | 16.10% | |||
Price | XRTX.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $5.32 | |||
52-Week Low Price | $1.18 | |||
52-Week Low Price (Date) | Feb 26, 2025 | |||
52-Week High Price (Date) | Apr 08, 2024 | |||
Valuation | XRTX.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 3.63M | |||
Enterprise Value | 1.18M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -1.35 | |||
Earnings Per Share Growth | 20.48% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | -- | |||
Price/Book (Q) | 0.69 | |||
Enterprise Value/Revenue (TTM) | -- | |||
Price | $1.42 | |||
Enterprise Value/EBITDA (TTM) | -0.41 | |||
Enterprise Value/EBIT | -0.45 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | XRTX.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 3.28M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | XRTX.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 403 455 7727 | |||
Address | 3710 – 33rd Street NW Alberta Beach, AB T2L 2M1 | |||
Website | www.xortx.com | |||
Country | Canada | |||
Year Founded | -- | |||
Profitability | XRTX.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -- | |||
Profit Margin | -- | |||
Management Effectiveness | XRTX.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -34.21% | |||
Return on Equity | -- | |||
Income Statement | XRTX.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | -- | |||
Total Revenue (TTM) | -- | |||
Revenue Per Share | -- | |||
Gross Profit (TTM) | -- | |||
EBITDA (TTM) | -2.90M | |||
EBIT (TTM) | -2.62M | |||
Net Income (TTM) | -3.31M | |||
Net Income Avl. to Common (TTM) | -3.31M | |||
Total Revenue Growth (Q YOY) | -- | |||
Earnings Growth (Q YOY) | -95.46% | |||
EPS Diluted (TTM) | -1.35 | |||
EPS Diluted Growth (Q YOY) | -97.24% | |||
Balance Sheet | XRTX.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 2.47M | |||
Cash Per Share (Q) | $0.76 | |||
Total Current Assets (Q) | 2.68M | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 3.34M | |||
Current Ratio (Q) | 3.531 | |||
Book Value Per Share (Q) | $1.98 | |||
Total Assets (Q) | 4.09M | |||
Total Current Liabilities (Q) | 758.00K | |||
Total Debt (Q) | 38.80K | |||
Total Liabilities (Q) | 758.00K | |||
Total Common Equity (Q) | 3.34M | |||
Cash Flow | XRTX.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -38.90K | |||
Cash from Financing (TTM) | 2.78M | |||
Net Change in Cash (TTM) | -974.00K | |||
Levered Free Cash Flow (TTM) | -694.50K | |||
Cash from Operations (TTM) | -3.68M | |||